Deep Pujara1, Paul Mansfield1, Jaffer Ajani2, Mariela Blum2, Elena Elimova2, Yi-Ju Chiang1, Prajnan Das3, Brian Badgwell1. 1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2. Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 3. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
OBJECTIVE: The purpose of this study was to identify clinical and geriatric assessment variables associated with outcome in patients with gastric adenocarcinoma who have undergone gastrectomy. METHODS: We reviewed demographic, clinical, and geriatric assessment variables, including recent falls, pain, performance status, American Society of Anesthesiologists score, assistive device use, comorbidity, polypharmacy, and weight change, for patients undergoing gastrectomy between 2005 and 2014. Outcome variables included morbidity, mortality, hospital length of stay, and readmission. RESULTS: Of 279 patients, 133 (48%) underwent total gastrectomy. The 90-day major morbidity rate was 24% and the mortality rate was 1%. Length of hospital stay ≥ 14 days occurred in 38%, with readmission within 30 days in 13%. On multivariate analysis, gastroesophageal junction involvement, (odds ratio [OR] 2.5, 95% confidence interval [1.1-5.8]), additional organ resection, (OR 3.2, [1.6-6.3]), pain score >0 (OR 3.8, [1.6-8.7]), Eastern Cooperative Oncology Group performance status >0, (OR 2.3, [1.2-4.6]), and polypharmacy (OR 2.4, [1.1-5.2]) were associated with major morbidity. Hospital stay ≥ 14 days was associated with age ≥ 75 years (OR 3.9, [1.7-9.2]), total gastrectomy (OR 3.5, [2.0-6.3]), performance status >0 (OR 1.8, [1.0-3.2]), and preoperative chemotherapy (OR 0.3, [0.2-0.7]). CONCLUSIONS: Future studies are needed to identify methods to improve performance status, as this may improve postoperative complications and resource utilization.
OBJECTIVE: The purpose of this study was to identify clinical and geriatric assessment variables associated with outcome in patients with gastric adenocarcinoma who have undergone gastrectomy. METHODS: We reviewed demographic, clinical, and geriatric assessment variables, including recent falls, pain, performance status, American Society of Anesthesiologists score, assistive device use, comorbidity, polypharmacy, and weight change, for patients undergoing gastrectomy between 2005 and 2014. Outcome variables included morbidity, mortality, hospital length of stay, and readmission. RESULTS: Of 279 patients, 133 (48%) underwent total gastrectomy. The 90-day major morbidity rate was 24% and the mortality rate was 1%. Length of hospital stay ≥ 14 days occurred in 38%, with readmission within 30 days in 13%. On multivariate analysis, gastroesophageal junction involvement, (odds ratio [OR] 2.5, 95% confidence interval [1.1-5.8]), additional organ resection, (OR 3.2, [1.6-6.3]), pain score >0 (OR 3.8, [1.6-8.7]), Eastern Cooperative Oncology Group performance status >0, (OR 2.3, [1.2-4.6]), and polypharmacy (OR 2.4, [1.1-5.2]) were associated with major morbidity. Hospital stay ≥ 14 days was associated with age ≥ 75 years (OR 3.9, [1.7-9.2]), total gastrectomy (OR 3.5, [2.0-6.3]), performance status >0 (OR 1.8, [1.0-3.2]), and preoperative chemotherapy (OR 0.3, [0.2-0.7]). CONCLUSIONS: Future studies are needed to identify methods to improve performance status, as this may improve postoperative complications and resource utilization.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: R A Pol; B L van Leeuwen; L Visser; G J Izaks; J J A M van den Dungen; I F J Tielliu; C J Zeebregts Journal: Eur J Vasc Endovasc Surg Date: 2011-07-31 Impact factor: 7.069
Authors: Jeremiah T Martin; Angela Mahan; Joseph B Zwischenberger; Patrick C McGrath; Ching-Wei D Tzeng Journal: J Am Coll Surg Date: 2014-12-29 Impact factor: 6.113
Authors: Megan A Feng; Daniel T McMillan; Karen Crowell; Hyman Muss; Matthew E Nielsen; Angela B Smith Journal: J Surg Res Date: 2014-07-05 Impact factor: 2.192
Authors: An Ngo-Huang; Holly M Holmes; Jude K A des Bordes; Nathan H Parker; David Fogelman; Maria Q B Petzel; Juhee Song; Eduardo Bruera; Matthew H G Katz Journal: Cancer Med Date: 2019-04-29 Impact factor: 4.452